$SSKN Secures Additional $12 Million Financing with MidCap Financial bit.ly/3D3p1TQ
English
CGCAPITAL
12K posts
CGCAPITAL
@CGCAP1TAL
CGCAPITAL is a capital markets development and equity research firm for small-to-midcap companies.
Atlanta Katılım Ekim 2011
249 Takip Edilen855 Takipçiler
$SSKN Dip Strong Buying Opportunity; Reiterate OUTPERFORM Rating, $4.00 Price Target
REPORT: hubs.ly/Q01VfV1D0
---
Rating: Outperform ... stocktwits.com/cgcapitalresea…
English
$PDSB ASCO Review: VERSATILE-002 Data Progress With Larger Sample; Reiterate Rating & $18 PT
REPORT: hubs.ly/Q01SztMd0
---
Rating: Outperform ... stocktwits.com/cgcapitalresea…
English
$ACHV Strong ORCA-3 Results Point Towards NDA, Alliances; Reiterate OUTPERFORM & $20 PT
REPORT: hubs.ly/Q01QWBGK0
---
Rating: Outperform ... stocktwits.com/cgcapitalresea…
English
$SSKN 1Q Review: 2023 Should Be a Period of Material Progress; Reiterate Rating, $4.00 PT
REPORT: hubs.ly/Q01Q2SyJ0
---
Rating: Outperform ... stocktwits.com/cgcapitalresea…
English
$PDSB 1Q Review: Fully On Track for VERSATILE-003 in 4Q23; Reiterate OUTPERFORM Rating & $18 PT
REPORT: hubs.ly/Q01Q2PGD0
---
Rating: Outperf... stocktwits.com/cgcapitalresea…
English
$ACHV 1Q Review: Getting Ready For Crucial Next Steps to Commercialization; Reiterate Rating & $20 PT
REPORT: hubs.ly/Q01Pm-Kw0
---
Rating: O... stocktwits.com/cgcapitalresea…
English
I just uploaded “02.02.23 Chris Bardon of MPM Capital on CNBC’s “The Exchange”” to #Vimeo: vimeo.com/825364639
English
$SSKN 1Q Preview: Should Be Start of Exciting 2023; Reiterate OUTPERFORM Rating, $4.00 PT
REPORT: hubs.ly/Q01P7Zy70
---
Rating: Outperform ... stocktwits.com/cgcapitalresea…
English
$PDSB 1Q Preview: Gearing Up for the First Phase 3 Trial for PDS0101; Reiterate Rating & $18 PT
REPORT: hubs.ly/Q01P7XBv0
---
Rating: Outperfo... stocktwits.com/cgcapitalresea…
English
$GOVX 1Q Review: Catalysts Remain Visible; Reiterating OUTPERFORM Rating, $6.00 Price Target
REPORT: hubs.ly/Q01NSwkN0
---
Rating: Outperform ... stocktwits.com/cgcapitalresea…
English
$ECOR 1Q Review: In a Race to Cash Flow Positive; Reiterate OUTPERFORM, PT of $30
VIEW FULL REPORT: hubs.ly/Q01NKRYM0
---
Rating: Outperform ... stocktwits.com/cgcapitalresea…
English
$GOVX 1Q Preview: Signs Remain Positive; Reiterating OUTPERFORM Rating, $6.00 Price TargetVIEW FULL REPORT: hubs.ly/Q01NbV6k0
---
Rating: Outperf... stocktwits.com/cgcapitalresea…
English
$ECOR 1Q Preview: Nearing Multiple Pivots; Reiterate OUTPERFORM, Price Target of $30
VIEW FULL REPORT: hubs.ly/Q01NbSmC0
---
Rating: Outperform ... stocktwits.com/cgcapitalresea…
English
$ACHV ORCA-V1 Phase II Data Highly Impressive; Reiterate OUTPERFORM Rating & $20 PT
VIEW FULL REPORT: hubs.ly/Q01MmRz20
---
Rating: Outperform ... stocktwits.com/cgcapitalresea…
English
$ECOR 1Q Pre-Announcement, 2023 Revenue Reiteration Show Momentum; Reiterate PT of $30
VIEW FULL REPORT: hubs.ly/Q01LWwXy0
---
Rating: Outperform ... stocktwits.com/cgcapitalresea…
English
$SSKN 4Q Review: Upside For Q Drives Momentum Into 2023; Reiterate Rating, $4.00 PT
VIEW FULL REPORT: hubs.ly/Q01J-gz20
---
Rating: Outperform ... stocktwits.com/cgcapitalresea…
English
$PDSB 4Q Review: Moving Forward with PDS0101 & VERSATILE; Reiterate Rating & $18 PT
VIEW FULL REPORT: hubs.ly/Q01JwLlt0
---
Rating: Outperform ... stocktwits.com/cgcapitalresea…
English
$GOVX 4Q Review: Good Things Happen to Those Who Wait; Reiterating OUTPERFORM Rating, $6.00 PT
VIEW FULL REPORT: hubs.ly/Q01JfGDC0
---
Rating: Outperfo... stocktwits.com/cgcapitalresea…
English
electroCore Reports Results of Pre-Clinical Trial in a Model of Traumatic Brain Injury bit.ly/3z0LwXO
English